Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.
Aberrant signaling through insulin (Ins) and insulin-like growth factor I (IGF1) receptors contribute to the risk and advancement of many cancer types by activating cell survival cascades. Similarities between these pathways have thus far prevented the development of pharmacological interventions th...
Enregistré dans:
Auteurs principaux: | Cemal Erdem, Adrian V Lee, D Lansing Taylor, Timothy R Lezon |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5a50932ee04e4320af6e668981cb0eb3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
par: Jingyi Liu, et autres
Publié: (2018) -
Tightly linked Rps12 and Rps13 genes provide broad-spectrum Phytophthora resistance in soybean
par: Dipak K. Sahoo, et autres
Publié: (2021) -
The molecular profile of luminal B breast cancer
par: Creighton CJ
Publié: (2012) -
MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis
par: Diala Kantar, et autres
Publié: (2021) -
FGFR1 Overexpression Induces Cancer Cell Stemness and Enhanced Akt/Erk-ER Signaling to Promote Palbociclib Resistance in Luminal A Breast Cancer Cells
par: Qiong Cheng, et autres
Publié: (2021)